Disagree
Home Beligas Pharmaceuticals Beligas Pharmaceuticals
IGF DES
IGF DES - Beligas Pharmaceuticals

IGF DES - Beligas Pharmaceuticals

Brand:
Category:
Substance:
Package:
1 mg
Price:
$210.00 - $210.00
See options
Product Overview

IGF-1 DES exhibits increased in vitro bioactivity due to its reduced affinity for IGFBPs, allowing for more unbound IGF-1 to interact directly with target tissues. This distinctive quality enables IGF-1 DES to reach high local concentrations, especially beneficial for potential CNS applications. In neurological research, it has shown promise for supporting glial cell proliferation and neuronal repair mechanisms, making it a target of interest for therapeutic approaches aimed at enhancing endogenous recovery pathways in brain injury.

References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about IGF DES by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What is the significance of reduced IGFBP binding?
Lower IGFBP binding lets IGF-1 DES reach higher concentrations in tissues, increasing its biological activity.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

How does IGF-1 DES affect the central nervous system (CNS)?
IGF-1 DES has potential in promoting neurological recovery by supporting cellular regeneration in injured brain regions.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers. 

What applications of IGF-1 DES are explored in CNS research?
It’s studied for glial cell proliferation, cellular regeneration, and possible neuroprotective roles after brain injury.
References:

Frontiers in CNS Drug Discovery (2011) Frontiers in CNS Drug Discovery. Bentham Science Publishers.